Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flow

v2.4.0.8
Consolidated Statements of Cash Flow (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Operating Activities    
Consolidated net income $ 21.6 $ 14.6
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 14.3 15.0
Deferred income taxes (5.4) 4.7
Share-based compensation 1.7 4.5
Trade accounts receivable and receivables on long-term manufacturing contracts 38.3 4.3
Inventories 0.4 8.4
Other current assets (2.1) (8.3)
Trade accounts payable (16.6) 0.2
Accrued expenses and other current liabilities (5.6) (25.3)
Income taxes payable (2.6) (1.2)
Defined benefit plan funding (4.2) (1.2)
Defined benefit plan expense 3.6 3.8
Other, net 2.5 0.2
Net cash provided by operating activities 45.9 19.7
Investing Activities    
Capital expenditures (5.6) (5.6)
Proceeds from sales of property, plant, and equipment   1.2
Proceeds from sales of investments   1.4
Acquisition of business, net of cash acquired   (415.6)
Other, net (0.6)  
Net cash used in investing activities (6.2) (418.6)
Financing Activities    
Proceeds from term loan   200.0
Repayments on term loan (2.5) (2.5)
Proceeds from revolving credit facilities, net of financing costs 94.2 535.3
Repayments on revolving credit facilities (105.9) (238.0)
Payment of dividends on common stock (12.4) (12.1)
Net proceeds (payments) on stock plans 7.6 (2.7)
Other, net (0.3)  
Net cash (used in) provided by financing activities (19.3) 480.0
Effect of exchange rates on cash and cash equivalents (0.8) 0.8
Net cash flows 19.6 81.9
Cash and cash equivalents:    
At beginning of period 42.7 20.2
At end of period $ 62.3 $ 102.1